rabbit polyclonal antibody against rac1 (Proteintech)
Structured Review

Rabbit Polyclonal Antibody Against Rac1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 165 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+rac1/pmc10854001-91-11-19?v=Proteintech
Average 96 stars, based on 165 article reviews
Images
1) Product Images from "The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma"
Article Title: The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma
Journal: Frontiers in Oncology
doi: 10.3389/fonc.2024.1347270
Figure Legend Snippet: The correlation of integrin αvβ6 expression and RAC1 expression with clinicopathologic variables in cases of gastric cancer.
Techniques Used: Expressing
Figure Legend Snippet: The manifestation of ITGB6 and Rac1 in diverse specimens. (A) Immunohistochemical staining exhibited diminished ITGB6 expression in adjacent normal tissues. (B) Immunohistochemical staining revealed elevated ITGB6 expression in tumor tissues. (C) ITGB6 expression in tumor tissues lacking lymphatic invasion. (D) ITGB6 expression in tumor tissues with lymphatic invasion. (E) Immunohistochemical staining displayed reduced Rac1 expression in adjacent normal tissues. (F) Immunohistochemical staining exhibited heightened Rac1 expression in tumor tissues. (G) Rac1 expression in tumor tissues without lymphatic invasion. (H) Rac1 expression in tumor tissues with lymphatic invasion.
Techniques Used: Immunohistochemical staining, Staining, Expressing
Figure Legend Snippet: (A) The level of ITGB6 expression was assessed using the H-score in both adjacent normal tissue specimens and tumor tissues. (B) The H-score of ITGB6 expression was evaluated in adjacent normal tissue specimens, comparing those with lymph node metastasis and those without. (C) We measured the H-score of Rac1 expression in both adjacent normal tissue specimens and tumor tissues. (D) The H-score of Rac1 expression was analyzed in adjacent normal tissue specimens, comparing those with lymph node metastasis and those without. *P<0.05; **P<0.001; ***P<0.0001.
Techniques Used: Expressing
Figure Legend Snippet: (A) Kaplan-Meier survival curves based on the ITGB6 gene expression level. (B) Kaplan-Meier survival curves based on the Rac1 gene expression level. (C) Receiver Operating Characteristic (ROC) analysis was conducted to predict the prognosis of gastric cancer patients using ITGB6 and Rac1 expression. (D) Receiver Operating Characteristic (ROC) analysis was conducted to predict lymph node metastasis in gastric cancer patients using ITGB6 and Rac1 expression.
Techniques Used: Gene Expression, Expressing
Figure Legend Snippet: The correlation between the expression of ITGB6 and Rac1 in human gastric tumor tissues (r =0.285, P <0.001).
Techniques Used: Expressing
Figure Legend Snippet: (A) Survival analysis was conducted on gastric cancer patients in a retrospective cohort, taking into consideration the combined levels of ITGB6 and Rac1. Based on the expression levels of ITGB6 and Rac1, the patients were classified into four groups, and subsequently, survival rates were calculated and represented using Kaplan-Meier curves. (B) In order to predict the prognosis of gastric cancer patients, a Receiver Operating Characteristic (ROC) analysis was performed, utilizing the combined expression levels of ITGB6 and Rac1.
Techniques Used: Expressing
Figure Legend Snippet: Univariate and multivariate analyses applying the Cox proportional hazard model to patients diagnosed with gastric cancer (Retrospective cohort).
Techniques Used: Significance Assay
Figure Legend Snippet: (A) Transfection of ITGB6 siRNA was conducted in the SGC7901 gastric cancer cell line, and the transfection efficiency was evaluated using RT-PCR. (B) After inhibiting the expression of ITGB6 in 7901 cells and treating them with the Rac1 activity inhibitor NSC23766, the cell viability was assessed using the CCK8 assays. (C) After interfering with ITGB6 expression in 7901 cells and treating them with the Rac1 activity inhibitor NSC23766, Transwell migration and invasion assays were performed to assess the changes in cell migration and invasion abilities. (D) Transfection of NC and ITGB6 siRNA was performed separately in 7901 cells, followed by treatment with NSC23766. Cell viability was evaluated using the CCK8 assay. (E) In the experiment, we performed co-transfection of NC and ITGB6 siRNA in 7901 cells, accompanied by NSC23766 treatment. The migration and invasion abilities of the cells were assessed through Transwell migration and invasion assays. *P<0.05; **P<0.001; ***P<0.0001
Techniques Used: Transfection, Reverse Transcription Polymerase Chain Reaction, Expressing, Activity Assay, Migration, CCK-8 Assay, Cotransfection


